This is a professional event for Health Care Professional (doctors, nurses, dentists, dermatologists, clinic owners, etc.).

Safe | Standardised | Regenerative

1# Next webinar

Register

Thursday, 12 March 2026 — 14:00–15:00 CET

RegenPRP and Combinations in everyday Women’s Health practice.

In this 1‑hour session, Dr Małgorzata Uchman‑Musielak will present a clear overview of how RegenPRP and RegenPRP–HA are used in everyday Women’s Health practice.
The webinar will cover the topics she frequently teaches in RegenLab and BioBridge programs, including:
  • GSM‑related symptoms (dryness, discomfort, dyspareunia) and how PRP and PRP‑HA help improve mucosal quality and hydration.
  • Post‑radiotherapy changes such as mucosal fragility and vulvar fibrosis, and the role of PRP in improving tissue condition.
  • Perineal scars and postoperative healing, with simple, practical notes on how she approaches injections and follow‑up.
  • Key points on PRP biology relevant to gynecology: growth‑factor release, tissue repair, and ECM support.
The focus of the session is straightforward: what PRP and PRP‑HA do, when Dr Uchman uses them, and what clinicians can expect in real cases.

2# Next webinar

Register

Thursday, 26 March 2026 — Schedule coming soon

Practical insights into RegenPRP–HA and RegenATS/BioFiller Skin/Face rejuvenation.

This session presents a clear, practical overview of how RegenPRP–HA, RegenPRP™, and ATS/BioFiller can be combined across everyday dermal-aesthetics.
You will learn how PRP–HA improves hydration and skin quality (fine lines, peri‑orbital aging, crepey skin, intimate dryness), how RegenPRP™ supports regeneration in texture damage and scars, and how ATS/BioFiller provides soft autologous structural lift for midface and perioral.
Expected clinical outcomes include:
  • Gradual ECM repair and texture improvement (RegenPRP™)
The webinar also covers the 8‑minute RegenATSxPRP biofiller prep/sequence, including fibrin thickening and mapped delivery.
From a practice/business perspective, this regenerative continuum (Hydrate → Support → Structure) helps clinics:
  • treat a wider range of indications with autologous‑only options,
  • improve patient satisfaction with natural progressive results,

UK webinar Agenda

From principles to offering: RegenPRP™-HA for GSM pathways

From principles to offering: RegenPRP™-HA for GSM pathways

Women’s Health

Thu 12 Mar | 14h – 15h CET
Held by :
Dr. Małgorzata Uchman Musielak

 RegenATS™ (Autologous Thrombin Serum) in 8 minutes: workflow & integration

 RegenATS™ (Autologous Thrombin Serum) in 8 minutes: workflow & integration

ATS/BioFiller / Practice Ops

Thu 26 Mar | 13h
Held by :
Sutha Bausbacher

Men’s regenerative health in motion

Men’s regenerative health in motion

Men’s Health 

Thu 09 Apr | 13h
Held by :
Dr. Greta Peciulyte, MD, FEBU

Register
Register
Register
CellularMatrix RegenPRP™-HA combinations (advanced Q&A)

CellularMatrix RegenPRP™-HA combinations (advanced Q&A)

Dermal/Aesthetics

Thu 23 Apr | 13h
Held by :
Dr. Yuliya Dyedyk Gusarova

 RegenPRP™-HA in urogenital care: pathway to practice

 RegenPRP™-HA in urogenital care: pathway to practice

Women’s Health

Thu 07 May | 13h
Held by :
Dr. Małgorzata Uchman Musielak

RegenATS™ (Autologous Thrombin Serum) workflow & integration playbook

RegenATS™ (Autologous Thrombin Serum) workflow & integration playbook

ATS/BioFiller / Practice Ops

Thu 21 May | 13h
Held by :
Sutha Bausbacher

 Mapping indications, risks & followup

 Mapping indications, risks & followup

Men’s Health 

Thu 04 Jun | 13h
Held by :
Dr. Greta Peciulyte, MD, FEBU

Register
Register
Register
Register

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

More

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

More

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

More

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

More

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

More

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

More

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

More

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

More

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

More

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.

More